Published on 12th December 2012
AIM-listed Scancell, the developer of therapeutic cancer vaccines, has announced that two key medical regulation bodies have given approval for a higher dose to be allowed in the company’s latest trials on a vaccine to treat melanoma.
URL: http://www.digitallook.com/dl/news/story/20562141/...